Coffee is a rich source of polyphenols, primarily chlorogenic acids (CGA) In conclusion, the present study has found no significant effect of 5-CGA, at 450 and 900 mg, on peak FMD response. However, there were significant improvements in mean post-ischaemic FMD response, particularly at the 1 hr time point in this group of healthy individuals.
Introduction
Dietary patterns characterised by high intake of fruits and vegetables are consistently associated with lower risk of chronic diseases, including cardiovascular disease (CVD). These beneficial effects are thought to arise from the abundance of nutrients and phytochemicals, including polyphenolic compounds, found in fruits and vegetables.(1) An important mechanism in the protection against CVD by these plant polyphenols is thought to be via lowering of blood pressure (BP) and improvements in endothelial function through changes in nitric oxide (NO) . NO is an important signalling molecule that is essential for the normal function of blood vessels. There is consistent evidence that certain polyphenols can improve endothelial function and lower blood pressure (BP) through effects on NO metabolism. (2) Coffee is one of the most widely consumed beverages in the world and represents an important dietary source of polyphenolic compounds. The major polyphenolic compounds found in coffee are chlorogenic acids (CGA), which represents ~86% of total polyphenol content. Coffee drinkers can have a daily intake of 0.5-1 g/day of CGA, while abstainers typically consume <100 mg/day.(3) While the predominant isomer found in coffee is 5-CGA, the actual amount and composition of coffee 
Methods

Study design
This was a double-blind, randomised, placebo controlled cross-over trial. Sixteen healthy men (n=6) and women (n=10) were recruited to the School of Medicine and Pharmacology, Research Studies Unit (Figure 1) . All participants were aged between 18 and 70 years of age and were regular consumers of coffee. Following an informed consent, participants underwent assessment of their flow-mediated dilatation (FMD).
Those with an FMD between 3 and 8% at screening were included into the study. 
Flow mediated dilatation
Brachial artery vasodilator function was assessed using ultrasound according to a previously published protocol. (13) 
Blood pressure assessment
Clinic blood pressure was monitored every 30 mins using a Dinamap 1846SX/P oscillometric recorder (Critikon, Tampa, FL, USA). Subjects were rested for 3 mins in a sitting position. A cuff was fitted to the right arm and 3 readings were taken, 1 min apart. The first reading was discarded and the second and third averaged to give a final BP. The BP data were analysed at each of the time points and as an overall 4 hr difference between treatment groups.
Plasma nitrite concentrations
Plasma nitrite concentration, as a reflection of overall nitric oxide status, was measured on freshly isolated plasma using gas phase chemiluminescence. Briefly, 
Results
Study participant characteristics
In total, 16 men and women were randomised into the study with 14 participants completing all four treatments. Their baseline characteristics are presented in Table 1 .
The mean age was 60 years (range: 39-69 years) and the mean screening FMD was 5.4% (± 1.2%).
Effects of 5-CGA on peak FMD response and continuous FMD response
There was no significant effect on peak FMD response for either dose of 5-CGA or the epicatechin at 1 hr or 4 hrs post-treatment ( Table 2) (Figure 2c ). There was no significant effect of epicatechin on mean continuous FMD response (data not shown).
Effects of 5-CGA on blood pressure
Blood pressure was measured every 30 mins from 0 hr until 4 hrs. At each time point, there was no significant difference between the 450 mg and 900 mg 5-CGA groups and control, for systolic BP or diastolic BP ( Table 3) . There was no effect of the 200mg epicatechin treatment on BP. There was a significant increase in BP across time, across all four treatments combined.
Effects of 5-CGA on plasma nitrite levels
Circulating plasma nitrite levels were measured as an index of overall NO production.
Relative to control, there was no significant effect of 450 mg and 900 mg 5-CGA or 200mg epicatechin onplasma nitrite concentrations ( Table 4) .
Circulating plasma CGA metabolites
The circulating plasma CGA metabolites were measured at baseline and at 1 hr and 4 hrs to confirm both compliance and absorbance of the compounds. There were significant increases in CGA metabolites following their respective treatments at both It is somewhat surprising that epicatechin, our positive control, had no effect on peak There are a number of limitations to consider when interpreting the results of the present study. Although the study was a randomised controlled cross-over study, the number of participants was small, with 14 completing all four treatment arms. This limited our power to detect a relatively small change in FMD response. Secondly, it might be that important time points have been missed in choosing when to measure FMD response. This is particularly noticeable when considering the lack of effect seen with epicatechin. The time points chosen for this study were based on peak times for CGA and its metabolites. Thirdly, although we recruited participants based a screening FMD response between 3-8%, they were considered to be otherwise healthy. This may mean that any observed benefit of the CGA compounds may have been too small to detect, as the participants weren't considered to be a high-risk group with endothelial dysfunction. Future studies in populations with existing CVD or preexisting CVD risk factors may help to elucidate the beneficial effects of this compound on vascular function. Furthermore, the use of an isolated compound, specifically 5-CGA, may have also limited the interpretation of our findings.
Although it is considered one of the major polyphenolic compounds in coffee, there are many other compounds present. Use of a single, purified compound in the present study may have meant that any additive or synergistic effects of other polyphenols also found in coffee (particularly after roasting), could not be observed.
In conclusion, there was no significant effect of 5-CGA or epicatechin on the peak FMD response, our primary outcome. We did observe a dose-related improvement in continuous mean FMD response for 5-CGA at 1 hr post ingestion, which was diminished by 4 hrs. Future studies examining whole coffee, as well as high-risk population groups, are warranted. Heart rate (bpm) 56.8 (7.4) Data are presented as mean (SD). Results are presented as mean systolic BP/mean diastolic BP (SD). Results are presented as mean (SD). 
